The UNC Lineberger Comprehensive Cancer Center requests renewal of its National Cancer Institute (NCI) Center Core Support Grant (CCSG) for Years 25-29. Over the past ten years and especially in the past five years, the UNC Lineberger has grown tremendously and emerged as a national leader in cancer research. Total National Cancer Institute (NCI) awards to Center members have tripled over the past ten years (1988: $7.2 million; 1993: $14.1 million; 1998: $22.6 million). In the past five years, the Center has recruited more than 25 new clinical and translational science members. Accrual to institutional to institutional therapeutic clinical trials at UNC has tripled (1993: 66; 1998: 190), while total accrual to therapeutic trials has almost doubled (1993: 188; 1998: 190), while total accrual to therapeutic trials has almost doubled (1993: 188; 1998: 347) in 1998. The Center has doubled the size of its headquarters building (39,000 to 80,000 nsf). The State budget has doubled and the Cancer Center, the UNC Hospitals, and the UNC School of Medicine entered into an enhanced and funded partnership ($1 million per year) that makes oncology and the Cancer Center a centerpiece of the emerging UNC Health Care System. Administratively, in 1993 the Center had direct responsibility for $15.1 million and had 211 employees on payroll. In 1998, the Center directly administers $32.4 million and has 517 employees on payroll. Under the leadership by Dr. H. Shelton """"""""Shelly"""""""" Earp the UNC Lineberger is well positioned to continued this remarkable growth over the next five years. The Cancer Center seeks significant new NCI Center Core Support Grant (CCSG) funding to match its expanded institutional commitment and continue its tradition of growth and development in collaborative cancer research. The total request of $3.495 million will support 10 scientific programs, 21 shared resources, five staff investigators, developmental funding, leadership, planning and evaluation, and administration. Requested support is approximately double the existing CCSG funding of $1,729 million. 85% of the increase is for seven specific requests, primarily for new and expanded shared resources. These requests are: New Shared Resources for Population Sciences: Expanded Shared Resources for Clinical Research; Expanded Shared Resources for Biostatistics; New Shared Resources for Translational and Basic Science; Expanded shared resources for Biostatistics; New Shared Resources for Translational and Basic Science; Expanded Shared Resources for Animal Models of Cancer; Increased Developmental Funding for Continued Expansion and Enhancement; and Staff Investigators in Key Developing Areas. Over the past 25 years and especially during the past decade, the Center has grown from a small center focused on basic laboratory science to large, truly comprehensive cancer center. With a strong tradition of growth and excellence, increased institutional commitment, and new leadership, and a strategic plan to guide development, the UNC Lineberger eagerly looks forward to continued development of its comprehensive programs over the next five years.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA016086-26S1
Application #
6447752
Study Section
Subcommittee G - Education (NCI)
Program Officer
Shafik, Hasnaa
Project Start
1981-08-01
Project End
2004-11-30
Budget Start
2001-04-25
Budget End
2001-11-30
Support Year
26
Fiscal Year
2001
Total Cost
$145,208
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Schulfer, Anjelique F; Battaglia, Thomas; Alvarez, Yelina et al. (2018) Intergenerational transfer of antibiotic-perturbed microbiota enhances colitis in susceptible mice. Nat Microbiol 3:234-242
Hall, Marissa G; Mendel, Jennifer R; Noar, Seth M et al. (2018) Why smokers avoid cigarette pack risk messages: Two randomized clinical trials in the United States. Soc Sci Med 213:165-172
Cholon, Deborah M; Gentzsch, Martina (2018) Recent progress in translational cystic fibrosis research using precision medicine strategies. J Cyst Fibros 17:S52-S60
Tappata, Manaswita; Eluri, Swathi; Perjar, Irina et al. (2018) Association of mast cells with clinical, endoscopic, and histologic findings in adults with eosinophilic esophagitis. Allergy 73:2088-2092
Che, Tao; Majumdar, Susruta; Zaidi, Saheem A et al. (2018) Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor. Cell 172:55-67.e15
Hu, Peirong; Bi, Yanmin; Ma, Hong et al. (2018) Superior lentiviral vectors designed for BSL-0 environment abolish vector mobilization. Gene Ther 25:454-472
Townsley, Loni; Yannarell, Sarah M; Huynh, Tuanh Ngoc et al. (2018) Cyclic di-AMP Acts as an Extracellular Signal That Impacts Bacillus subtilis Biofilm Formation and Plant Attachment. MBio 9:
DeBono, Nathan L; Robinson, Whitney R; Lund, Jennifer L et al. (2018) Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study. J Womens Health (Larchmt) 27:377-386
Okolie, Onyinyechukwu; Irvin, David M; Bago, Juli R et al. (2018) Intra-cavity stem cell therapy inhibits tumor progression in a novel murine model of medulloblastoma surgical resection. PLoS One 13:e0198596
van Haren, Jeffrey; Charafeddine, Rabab A; Ettinger, Andreas et al. (2018) Local control of intracellular microtubule dynamics by EB1 photodissociation. Nat Cell Biol 20:252-261

Showing the most recent 10 out of 1525 publications